TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
MNPR

Monopar Therapeutics Inc

Healthcare · Biotechnology

85.20$ -4.1% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement MNPR
Line item 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – – – – – -100.0% – – – –
– – – – – – – – – – –
– +176.2% +5,406.2% -88.5% +10.9% +106.5% +59.7% +16.9% -26.2% +132.2% +76,051.3%
– +55.4% +27.8% +39.6% +44.6% +3.8% +7.8% +11.8% +9.7% -2.3% +215,386.7%
– +73.2% +1,291.9% -79.5% +27.1% +50.5% +40.2% +15.4% -16.2% +83.0% +3.4%
– – – – – – – – – – –
– – +567.2% +113.9% -4.2% -17.2% -70.7% -11.6% – – –
– – – – – – – – – – –
– – -262,788.1% – – – – – – – –
– – – – – – – – – – –
– -95,450.0% – – – – – – – – –

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?